Cost and Access for Non-Diabetic GLP-1 Users PlexusDx eliminates insurance barriers by offering direct-to-patient compounded semaglutide, tirzepatide, and combination GLP-Squared formulations without membership fees or insurance requirements
Wang L, Wang N, Zhang W, et al.: Therapeutic peptides: Current applications and future directions
Growth hormone released from the pituitary stimulates liver IGF-1 production, linking CJC-1295 research to downstream GH/IGF-1 pathway signaling 3
The high price of brand-name GLP-1 medications is one of the biggest challenges for patients seeking obesity treatment (BMI 30 or more), overweight (BMI 27 or more), and type 2 diabetes mellitus
Are uncomfortable with self-administered injectable treatments: Several popular options - NAD+ injections, glutathione injections, sermorelin injections, B12 injections - require home self-administration